XML 42 R30.htm IDEA: XBRL DOCUMENT v3.20.2
SUPPLEMENTAL EQUITY INFORMATION (Tables)
3 Months Ended
Mar. 29, 2020
SUPPLEMENTAL EQUITY INFORMATION  
Schedule of components of accumulated other comprehensive loss, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

    

 

 

    

Other

    

 

 

 

 

 

Minimum

 

Comprehensive

 

 

 

 

 

 

Pension and

 

Loss

 

 

 

 

 

 

Post-

 

Related to

 

 

 

 

 

 

Retirement

 

Equity

 

 

 

 

(in thousands)

 

Liability

 

Investments

 

Total

 

Balance at December 29, 2019

 

$

(567,670)

 

$

(8,469)

 

$

(576,139)

 

Amounts reclassified from AOCL

 

 

6,735

 

 

 —

 

 

6,735

 

Other comprehensive income

 

 

6,735

 

 

 —

 

 

6,735

 

Balance at March 29, 2020

 

$

(560,935)

 

$

(8,469)

 

$

(569,404)

 

 

Schedule of reclassification out of accumulated other comprehensive income

 

 

 

 

 

 

 

 

 

Amount Reclassified from AOCL

 

 

 

Three Months Ended

    

 

(in thousands)

March 29,

 

March 31,

 

Affected Line in the Condensed

AOCL Component

2020

 

2019

 

Consolidated Statements of Operations

Minimum pension and post-retirement liability

$

6,735

   

$

4,807

 

Retirement benefit expense (1)

_____________________

(1) There is no income tax benefit associated with the three months ended March 29, 2020, or March 31, 2019, due to the recognition of a valuation allowance. 

Summary of the restricted stock units ("RSUs") activity

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

Average Grant

 

 

 

 

Date Fair

 

    

RSUs

    

Value

Nonvested — December 29, 2019

 

413,466

 

$

7.00

Vested

 

(205,028)

 

$

7.55

Forfeited

 

(975)

 

$

6.46

Nonvested — March 29, 2020

 

207,463

 

$

6.45

 

Summary of the stock appreciation rights ("SARs") activity

The following table summarizes the stock appreciation rights (“SARs”) activity during the three months ended March 29, 2020: 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Weighted

    

Aggregate

 

 

 

 

Average

 

Intrinsic Value

 

    

SARs

    

Exercise Price

    

(in thousands)

Outstanding December 29, 2019

 

88,875

 

$

31.61

 

$

 —

Outstanding March 29, 2020

 

88,875

 

$

31.61

 

$

 —

 

Summary of stock-based compensation expense

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

March 29,

 

March 31,

(in thousands)

 

2020

 

2019

Stock-based compensation expense

    

$

406

 

$

663

 

Summary of anti-dilutive stock options

 

 

 

 

 

 

 

Quarters Ended

 

 

March 29,

 

March 31,

(shares in thousands)

 

2020

 

2019

Anti-dilutive common stock equivalents

    

360

    

160